NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat therapy tested for Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether a combination of three investigational drugs is safe and effective for people with advanced non-small cell lung cancer whose disease has progressed after prior immunotherapy. The trial will enroll about 30 participants to see if the three drugs worki…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test drug combo to outsmart aggressive lung cancer
Disease control OngoingThis study is testing if a targeted drug (osimertinib) works better alone or combined with two chemotherapy drugs for people with advanced non-small cell lung cancer who have two specific genetic changes (EGFR and TP53 mutations). It aims to see which approach better controls the…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Li Zhang, MD • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Custom immune cells unleashed against multiple cancers in pioneering trial
Disease control OngoingThis early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Blood test aims to reduce unnecessary lung biopsies
Diagnosis OngoingThis study is testing whether a blood test called Nodify XL2 helps doctors better manage small, solid lung nodules found on CT scans. It involves 2,000 adults over 40 whose nodules are considered low to moderate risk for cancer. The goal is to see if the test results lead to fewe…
Matched conditions: NON-SMALL CELL CARCINOMA
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC